ByHeart says all its baby formula could be tainted with botulism
ByHeart, a company known for producing baby formula, has recently come under fire for a botulism outbreak linked to its products that has affected numerous infants across the United States. The company has issued a statement acknowledging that all of its formula may have been contaminated.
According to a post on ByHeart’s website on November 24th, five out of 36 samples tested positive for Clostridium botulinum Type A, the bacteria responsible for causing botulism. This discovery led the company to express concern that all of its formula, across all product lots, could potentially be tainted.
As of November 19th, there have been at least 31 reported cases of infant botulism in 15 states connected to various shipments of ByHeart’s Whole Nutrition infant formula, as reported by the FDA. Fortunately, no deaths have been reported in relation to this outbreak.
Symptoms of infant botulism can take weeks to manifest and may include issues such as poor feeding, loss of head control, drooping eyelids, and a flat facial expression. Babies affected by this illness may also experience difficulties with swallowing or breathing.
Medical experts have pointed out that Clostridium botulinum can be unevenly distributed throughout powdered formula, meaning that not all infants who consume a contaminated product will necessarily become ill. Despite a recall of the formula, the FDA stated on November 20th that reports indicated ByHeart formula was still available at major retailers.
In response to the situation, ByHeart announced that it will be offering full refunds for all products purchased through its website on or after August 1st. The company is actively investigating the root cause of the contamination, conducting thorough audits of its product development chain and testing additional product samples.
Some parents of infants affected by the tainted formula have taken legal action against ByHeart, filing lawsuits alleging product defects and negligence on the company’s part. These parents are seeking compensation for medical expenses, emotional distress, and other damages.
It is essential for parents and caregivers to be vigilant about the products they use for their infants and to stay informed about any recalls or safety alerts. ByHeart’s ongoing efforts to address the botulism outbreak underscore the importance of transparency and accountability in the manufacturing and distribution of infant formula.
This article was contributed by The Associated Press and edited by Alain Sherter.
